Medication-induced exacerbation of neuropathy in Charcot Marie Tooth Disease
Authors:
- Louis H. WeimerLWLouis H. Weimer
- David PodwallDPDavid Podwall
- 1 March 2006
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 242 (1-2) , 47-54
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Medication and Toxin-Induced Peripheral NeuropathySeminars in Neurology, 2005
- Peripheral neuropathy in patients treated with leflunomide*1Clinical Pharmacology & Therapeutics, 2004
- Toxic neuropathy in patients with pre-existing neuropathyNeurology, 2003
- Medication-induced peripheral neuropathyCurrent Neurology and Neuroscience Reports, 2003
- Recent advances in drug-induced neuropathiesCurrent Opinion in Neurology, 2002
- Statins and risk of polyneuropathyNeurology, 2002
- The Gene for Slow Wallerian Degeneration (Wlds) Is Also Protective against Vincristine NeuropathyNeurobiology of Disease, 2001
- Mitochondrial ribosomal RNA mutation associated with both antibiotic–induced and non–syndromic deafnessNature Genetics, 1993
- Acute vincristine neurotoxicity in the presence of hereditary motor and sensory neuropathy type IMedical and Pediatric Oncology, 1989
- Vincristine NeurotoxicityNew England Journal of Medicine, 1972